Next Article in Journal
Modular Synthesis of Polyphenolic Benzofurans, and Application in the Total Synthesis of Malibatol A and Shoreaphenol
Next Article in Special Issue
Antifungal Properties of Chenopodium ambrosioides Essential Oil Against Candida Species
Previous Article in Journal
Cytotoxic Tirucallane Triterpenoids from Melia azedarach Fruits
Previous Article in Special Issue
Conazoles
Article Menu

Article Versions

Export Article

Open AccessReview
Molecules 2010, 15(9), 5878-5908; doi:10.3390/molecules15095878

Discovery and Development of Anti-HBV Agents and Their Resistance

1
Department of Pharmacology, School of Medicine, and Center for Cancer Research and Diagnostic Medicine, IBST, Konkuk University, Seoul 143-701, Korea
2
Research Institute of Medical Sciences, Konkuk University, Seoul 143-701, Korea
3
R&D Center, Equispharm Inc., 11F Gyeonggi Bio-Center, 864-1 Iui-Dong, Yeongtong-gu, Suwon-Shi, Gyeonggi-Do 443-766, Korea
4
Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Korea
5
Translational Research Center for Protein Function Control, Yonsei University, Seoul 120-749, Korea
*
Authors to whom correspondence should be addressed.
Received: 4 August 2010 / Revised: 24 August 2010 / Accepted: 26 August 2010 / Published: 27 August 2010
(This article belongs to the Special Issue Anti-Infective Agents)
Download PDF [642 KB, uploaded 18 June 2014]   |  

Abstract

Hepatitis B virus (HBV) infection is a prime cause of liver diseases such as hepatitis, cirrhosis and hepatocellular carcinoma. The current drugs clinically available are nucleot(s)ide analogues that inhibit viral reverse transcriptase activity. Most drugs of this class are reported to have viral resistance with breakthrough. Recent advances in methods for in silico virtual screening of chemical libraries, together with a better understanding of the resistance mechanisms of existing drugs have expedited the discovery and development of novel anti-viral drugs. This review summarizes the current status of knowledge about and viral resistance of HBV drugs, approaches for the development of novel drugs as well as new viral and host targets for future drugs.
Keywords: hepatitis B virus; antiviral agent; drug development; drug resistance; modeling; rational drug design hepatitis B virus; antiviral agent; drug development; drug resistance; modeling; rational drug design
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Kim, K.-H.; Kim, N.D.; Seong, B.-L. Discovery and Development of Anti-HBV Agents and Their Resistance. Molecules 2010, 15, 5878-5908.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top